Jordan Levy
About Jordan Levy
Jordan Levy is an independent director of Core Scientific (CORZ), serving since January 23, 2024, and currently chairs the Nominating and Corporate Governance Committee . He is Managing Partner at SBNY and previously spent 16 years as a Partner on the early-stage investing team at SoftBank Capital; earlier, he co-founded and led ClientLogic and its predecessor UCA (now SITEL Worldwide) and SoftBank Services Group . Levy holds a B.A. in Political Science from the State University of New York at Buffalo and is 69 years old . The Board affirmatively determined Levy is independent under Nasdaq standards .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| SoftBank Capital | Partner, early-stage investing team | 16 years | Led early-stage investing; board representation at portfolio companies |
| ClientLogic | Co-founder and President | Not disclosed | Built customer services; preceded UCA/SITEL Worldwide |
| UCA / SoftBank Services Group (now SITEL Worldwide) | President, co-CEO, co-Chairman | Not disclosed | Scaled business services platform |
| Software Distribution Services | Co-founder | Not disclosed | Company acquired by Ingram Micro (NYSE: INGM) |
| Cobalt Networks; GT Interactive | Founding director | Not disclosed | Early leadership in tech/media firms |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Synacor (Nasdaq: SYNC) | Non‑Executive Chairman | Not disclosed | Current public company role |
| BuzzFeed (Nasdaq: BZFD) | Director | Not disclosed | Current public company role |
| JackThreads; RebelMouse; Shareablee; SocialFlow; Spanfeller Media; TalkSpace; WildCard; Work Market | Director | Not disclosed | Current board roles (mix of private/media/tech) |
| 43North | Chairman | Not disclosed | Global business plan competition |
| Z80 Labs | Co‑founder | Not disclosed | Startup incubator in Buffalo |
| Federal Reserve Bank of New York (Upstate Regional Advisory Board) | Board member (prior) | Not disclosed | Regional advisory engagement |
| University at Buffalo Foundation | Trustee | Not disclosed | Academic foundation governance |
Board Governance
- Committee assignments: Levy chairs Nominating and Corporate Governance; not on Audit or Compensation .
- Independence: Board determined Levy and the other non‑employee directors are independent under Nasdaq rules .
- Board leadership: Separate CEO and Chair roles; Jarrod Patten serves as independent Chair since January 23, 2024 .
- Meetings/attendance: In 2024, the Board held 13 meetings; each director attended more than 75% of total Board and committee meetings .
- Governance proposals: Management seeks to declassify the Board by 2026 (Proposal 4), remove supermajority voting provisions (Proposal 5), and eliminate creditor consent rights no longer needed post‑emergence (Proposal 6) .
Fixed Compensation
| Component | 2024 Terms | 2025 Terms | Notes |
|---|---|---|---|
| Annual Board retainer (cash) | $100,000 | $100,000 | All eligible directors |
| Chair of Board retainer (cash) | $50,000 | $75,000 | Applies to Board Chair (not Levy) |
| Committee Chair fees (cash) | Audit $25,000; Compensation $25,000; Nominating & Gov $10,000 | Same | Levy receives $10,000 as N&CG Chair |
| Committee member fees (cash) | Not specified for 2024 | Audit $10,000; Compensation $7,500; N&CG $5,000 | Introduced in 2025 |
| 2024 Fees earned (Levy) | $110,000 | — | Reported fees earned in 2024 |
Performance Compensation
| Award | Grant Size/Value | Vesting | Performance Metrics |
|---|---|---|---|
| 2024 one‑time RSU grant (on appointment) | 127,446 RSUs | Vests on 3rd anniversary of grant date (time‑based) | Not applicable (time‑based) |
| 2024 annual RSU grant | 47,793 RSUs | Vests on Jan 23, 2025 (time‑based) | Not applicable (time‑based) |
| 2024 Stock awards (reported value) | $844,651 | Per above schedules | Reported grant‑date fair value |
| 2025 annual director grant | $300,000 RSUs (e.g., 20,448 RSUs granted in Jan 2025) | Vests one year from grant date | Two‑thirds of value to be performance‑based awards; specific metrics not disclosed |
Clawback and anti‑repricing: Awards under the Restated Plan are subject to the company’s clawback policy; repricing of options/SARs without shareholder approval is prohibited .
Other Directorships & Interlocks
- Public boards: Synacor (non‑executive Chairman) and BuzzFeed (director) .
- Related party/transactions: The company reports no transactions with related persons since January 1, 2024 .
- Interlocks: No disclosed overlaps with Core Scientific’s customers/suppliers; Audit Committee oversight of related person transactions is in place .
Expertise & Qualifications
- Early‑stage venture investing, technology evaluation, and governance leadership across multiple boards .
- Co‑founder/operator experience in customer services and tech distribution businesses .
- Education: B.A. in Political Science, SUNY Buffalo .
- The Board cites Levy’s public company board service and technology investing background as strategic and governance assets .
Equity Ownership
| Item | Amount | Notes |
|---|---|---|
| Beneficial ownership (common shares) | 158,993 | As of March 14, 2025 |
| Ownership % | <1% | Company disclosure “Less than 1%” for directors |
| Unvested RSUs (as of Dec 31, 2024) | 175,239 | Each non‑employee director had 175,239 unvested RSUs |
| Hedging/pledging | Prohibited | Insider trading policy prohibits hedging, short selling, margin purchases, and pledging by directors |
Governance Assessment
-
Positive signals:
- Independence and committee leadership (Levy chairs N&CG) support board effectiveness and refreshment oversight .
- Strong attendance (>75%), separate Chair/CEO roles, and pursuit of declassification/supermajority removal enhance accountability .
- No related‑party transactions; insider policy prohibits hedging/pledging; clawback policy applies to equity awards .
-
Watch items / potential risks:
- Director equity increased meaningfully (2024 stock awards $844,651) with 2025 annual RSU grants at $300,000; two‑thirds of director equity expected to be performance‑based but specific criteria are not disclosed, creating opacity in pay‑for‑performance alignment at the director level .
- Aggregate annual cap for non‑employee director compensation is $800,000 under the Restated Plan, which sets an upper boundary but still warrants monitoring for pay inflation .
-
Overall: Levy’s profile—independent status, governance chair role, and broad tech investing/board experience—supports board oversight at CORZ; continued transparency on director performance award criteria and measured use of equity will be important for investor confidence .